Literature DB >> 16957031

Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.

Pierre Bogaerts1, Thierry Naas, Ingrid Wybo, Caroline Bauraing, Oriane Soetens, Denis Piérard, Patrice Nordmann, Youri Glupczynski.   

Abstract

Carbapenem-resistant Acinetobacter baumannii isolates were obtained from 17 patients between September 2004 and August 2005 at the Academisch Ziekenhuis Vrije Universiteit Brussel, Brussels, Belgium. These multidrug-resistant isolates, which belonged to a single clone, remained susceptible to colistin and tigecycline only and produced the carbapenem-hydrolyzing oxacillinase OXA-58. This study highlights the importance of the intercountry spread of this beta-lactamase-mediated resistance mechanism and its epidemic evolution.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16957031      PMCID： PMC1698292          DOI： 10.1128/JCM.00796-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  22 in total

1.  Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92.

Authors:  H M Donald; W Scaife; S G Amyes; H K Young
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

Review 2.  Emerging carbapenemases in Gram-negative aerobes.

Authors:  P Nordmann; L Poirel
Journal:  Clin Microbiol Infect       Date:  2002-06       Impact factor: 8.067

3.  Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents.

Authors:  Juliana Coelho; Neil Woodford; Mariya Afzal-Shah; David Livermore
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

4.  Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit.

Authors:  S Pournaras; A Markogiannakis; A Ikonomidis; L Kondyli; K Bethimouti; A N Maniatis; N J Legakis; A Tsakris
Journal:  J Antimicrob Chemother       Date:  2006-01-23       Impact factor: 5.790

5.  Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1.

Authors:  A Loli; L S Tzouvelekis; E Tzelepi; A Carattoli; A C Vatopoulos; P T Tassios; V Miriagou
Journal:  J Antimicrob Chemother       Date:  2006-07-26       Impact factor: 5.790

6.  Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii.

Authors:  M Afzal-Shah; N Woodford; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

7.  Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii.

Authors:  Claire Héritier; Laurent Poirel; Pierre-Edouard Fournier; Jean-Michel Claverie; Didier Raoult; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

8.  Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe.

Authors:  Sophie Marqué; Laurent Poirel; Claire Héritier; Sylvain Brisse; Maria Dolores Blasco; Roxana Filip; Gabriela Coman; Thierry Naas; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

9.  Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii.

Authors:  Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

Review 10.  Acquired carbapenem-hydrolyzing beta-lactamases and their genetic support.

Authors:  L Poirel; P Nordmann
Journal:  Curr Pharm Biotechnol       Date:  2002-06       Impact factor: 2.837
View more
  20 in total

1.  GES extended-spectrum β-lactamases in Acinetobacter baumannii isolates in Belgium.

Authors:  Pierre Bogaerts; Thierry Naas; Farid El Garch; Gaelle Cuzon; Ariane Deplano; Tugba Delaire; Te-Din Huang; Benedicte Lissoir; Patrice Nordmann; Youri Glupczynski
Journal:  Antimicrob Agents Chemother       Date:  2010-08-30       Impact factor: 5.191

Review 2.  Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside.

Authors:  Ming-Feng Lin; Chung-Yu Lan
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

Review 3.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

4.  Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii.

Authors:  Alexandros Ikonomidis; Evangelia Neou; Vassiliki Gogou; Georgia Vrioni; Athanassios Tsakris; Spyros Pournaras
Journal:  J Clin Microbiol       Date:  2009-10-14       Impact factor: 5.948

Review 5.  Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence.

Authors:  Drosos E Karageorgopoulos; Theodore Kelesidis; Iosif Kelesidis; Matthew E Falagas
Journal:  J Antimicrob Chemother       Date:  2008-04-24       Impact factor: 5.790

Review 6.  OXA β-lactamases.

Authors:  Benjamin A Evans; Sebastian G B Amyes
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 7.  Diversity, epidemiology, and genetics of class D beta-lactamases.

Authors:  Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

8.  Dissemination of carbapenem-resistant Acinetobacter baumannii strains carrying the bla GES, bla NDM and bla OXA23 in Morocco.

Authors:  Hanane El Hafa; Kawtar Nayme; Najia El Hamzaoui; Itto Maroui; Mohammed Sbiti; Khalid Zerouali; Mohammed Timinouni; Abdelhaq Belhaj
Journal:  Germs       Date:  2019-09-02

9.  Complete genome analysis of three Acinetobacter baumannii clinical isolates in China for insight into the diversification of drug resistance elements.

Authors:  Lingxiang Zhu; Zhongqiang Yan; Zhaojun Zhang; Qiming Zhou; Jinchun Zhou; Edward K Wakeland; Xiangdong Fang; Zhenyu Xuan; Dingxia Shen; Quan-Zhen Li
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

10.  Acinetobacter baumannii producing OXA-23 detected in the Czech Republic.

Authors:  Marketa Senkyrikova; Vendula Husickova; Magdalena Chroma; Pavel Sauer; Jan Bardon; Milan Kolar
Journal:  Springerplus       Date:  2013-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.